Teva has launched a new patient-centric brand in the UK, marked by a “refreshed visual identity” and a new digital platform entitled ‘Life Effects’.

The rebrand will be launched at the 2019 NHS Health and Care Innovation Expo in Manchester, after being drawn from insights from more than 1,000 patients across the UK.

The platform is shaped by patients for patients, and shines a light on their real-world experiences and stories.

It consists of articles, videos and podcasts that offer information, insight and inspiration to people suffering from one or more chronic conditions, including multiple sclerosis, migraine or mental health, with a particular focus on the impact a condition has on a patient’s day-to-day life.

Teva announced that by working with a core group of patient contributors on an ongoing basis, Life Effects is able to offer a first-hand, credible perspective on what it’s like to live with a chronic condition.

The company will also take on a new logo, which will start to roll out on new packaging for the company’s medicines in 2020.

“The launch of the new Teva brand in the UK is about keeping patients at the heart of everything we do,” said Kim Innes, general manager of Teva UK & Ireland.

Kim continued, “New initiatives such as the Life Effects platform, new next-generation packs and our support for pharmacies, strengthens our position as a leading contributor to patient health and wellbeing across the UK. We’re proud of the work we do and the opportunity that the new brand offers us to connect even better with patients and healthcare professionals across the country.”